The HinduLean L·
Alembic Pharma Q2 net surges 81% to ₹335 crore
“U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said
Read at The Hindu →
Business · 1 sources covering this
Alembic Pharma Q2 net surges 81% to ₹335 crore
“U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/c905cd5e0b411395c7cc5c4b89b2128c83dc109f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Alembic Pharma Q2 net surges 81% to ₹335 crore"></iframe>
